Galderma Group N (GALD) — Capital Reinvestment Ratio
Latest as of June 2025:
0.08x
Galderma Group N (GALD) has a Capital Reinvestment Ratio of 0.08x as of June 2025, meaning it reinvests 0% of its operating cash flow (CHF475.06 Million) in capital expenditures (CHF37.07 Million). See free cash flow generation of Galderma Group N to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.08x
Capex / Operating Cash Flow
Operating Cash Flow
CHF475.06 Million
CHF
Capital Expenditures
CHF37.07 Million
CHF
Data as of
Jun 2025
Most recent filing
Galderma Group N Capital Reinvestment Ratio (2021–2024)
This chart tracks Galderma Group N's Capital Reinvestment Ratio across 4 annual periods.
Annual Capital Reinvestment Ratio for Galderma Group N (2021–2024)
Year-by-year Capital Reinvestment Ratio for Galderma Group N from 2021 to 2024. For live market cap and broader valuation context, see market value of Galderma Group N.
| Year | Reinvestment Ratio | Operating CF (CHF) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.64x | CHF429.77 Million | CHF275.00 Million | ▼ -6.8% |
| 2023 | 0.69x | CHF148.64 Million | CHF102.02 Million | ▼ -52.1% |
| 2022 | 1.43x | CHF106.30 Million | CHF152.33 Million | ▲ +119.1% |
| 2021 | 0.65x | CHF178.92 Million | CHF117.03 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow